FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Search FDA Site | FDA A-Z Index | Contact FDA

horizonal rule

FDA PUBLIC CALENDAR

Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.

fdalogo

October 30, 2005

fdalogo

FDA Official and Title

Date and Site

Other FDA Participants

Non-FDA Participants

Subject

Margaret Glavin, Associate Commissioner of Regulatory Affairs 10/2/05 None Booz-Allen Booz-Allen Team Feedback to the CTR Survey Results
Margaret Glavin, Associate Commissioner of Regulatory Affairs 10/19/05 None None National Association of Board of Pharmacy Meeting
Janet Woodcock, M.D.
Deputy Commissioner for Operations
10/19/05
Arlington, VA
Larry Kessler, CDRH
Miriam Provost, CDRH
Brett Giroir, MD
Defense Advanced Research Projects Agency
Defense Advanced Research Projects Agency (DARPA)
Speaker:  General Intro to FDA Critical Path
Janet Woodcock, M.D.
Deputy Commissioner for Operations
10/21/05
Mayflower Hotel
Washington, DC
  Steve Case/John Reher/Gaynor Nichols ABC2 Annual Meeting
Speaker - panel
Janet Woodcock, M.D.
Deputy Commissioner for Operations
10/26/05 Doug Throckmorton, CDER   Bio Discovery Online Conference
Opportunities for Improving Early Drug Development
Janet Woodcock, M.D.
Deputy Commissioner for Operations
10/26/05
San Francisco, CA
George Mills, MD Dr. Larry Horowitz
Stanford University
Speaker – The Critical Path Initiative: Background, Updates & Next Steps
Sheldon T. Bradshaw, Chief Counsel 10/17/05 FDA/Rockville, MD Beverly Chernaik and Mark Raza, OCC June Austin, Keith Triebwasser, Proctor & Gamble; Ellen Flannery, Covington & Burling Medical Device Regulations
Sheldon T. Bradshaw, Chief Counsel 10/18/05 FDA/Washington, DC None John Bleder, Jeff Gibbs, Roger Thies, and Frank Sasinowski; Hyman, Phelps & McNamara Introductory/Courtesy Visit
Sheldon T. Bradshaw, Chief Counsel 10/20/05 FDA/Washington, DC None Wayne Pines, Apco Worldwide Courtesy
Sheldon T. Bradshaw, Chief Counsel 10/20/05 FDA/Washington, DC None Apco Worldwide Representatives Introductory/Courtesy Visit
Sheldon T. Bradshaw, Chief Counsel 10/20/05 FDA/Washington, DC None Members of ABA Committee on Health Law Section Spoke at meeting
Sheldon T. Bradshaw, Chief Counsel 10/20/05 FDA/Washington, DC None Peter Barton Hutt and Scott Cunningham; Covington & Burling Drug Labeling Issue
Sheldon T. Bradshaw, Chief Counsel 10/24/05 FDA/Rockville, MD Bill McConagha, OCC Rebecca L. Myers, Rotech Healthcare, Inc.; R. Hathaway, John Manthei, Latham & Watkins Compounding Issues
Jesse L. Goodman, MD, MPH, Director, CBER 10/25-28/05 Washington, DC Unknown Other Participants, names unknown Participated in Institute of Medicine Workshop, "Protecting Against Foodborne Threats to Health"
Sheldon T. Bradshaw, Chief Counsel 11/2/05 Washington, DC None Board Members of Food and Drug Law Institute Spoke at Luncheon

horizonal rule